Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (3)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Fullerton, K E
Right arrow Articles by Reef, S E
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fullerton, K E
Right arrow Articles by Reef, S E
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

International Journal of Epidemiology 2002;31:983-984
© International Epidemiological Association 2002

Special Theme: Infectious Diseases

Commentary: Ongoing debate over the safety of the different mumps vaccine strains impacts mumps disease control

K E Fullerton and S E Reef

National Immunization Program, Centers for Disease Control and Prevention, 1600 Clifton Rd NE MS E-61, Atlanta, GA 30333, USA.

The first 10% of the full text of this article appears below.

The worldwide use of vaccines has resulted not only in significant achievements in controlling disease but also in disease eradication; smallpox was eradicated in 1977 and there is a global goal for polio eradication by 2005. Additionally, global efforts are already underway towards accelerated measles control. In 1992, mumps disease was recognized as one of six potentially eradicable diseases by the International Task Force for Disease Eradication (ITFDE).1 The ITFDE is a group of scientists convened through the Carter Center of Emory University in Atlanta, GA, that met from 1989 to 1992 to evaluate the potential for eradication of more than 90 diseases. The ITFDE also recognized the potential for . . . [Full Text of this Article]


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Am. J. Public HealthHome page
P. I. Folb, E. Bernatowska, R. Chen, J. Clemens, A. N. O. Dodoo, S. S. Ellenberg, C. P. Farrington, T. J. John, P.-H. Lambert, N. E. MacDonald, et al.
A Global Perspective on Vaccine Safety and Public Health: The Global Advisory Committee on Vaccine Safety
Am J Public Health, November 1, 2004; 94(11): 1926 - 1931.
[Abstract] [Full Text] [PDF]